Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00690527
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
183 | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)- DIONE | A,B,C,D,E,F | 1U1F | 0.71 | |
0E4 | N-acetyl-L-tyrosyl-L-valyl-L-alanyl- L-aspartic acid | B,D | 3GJS | 0.7 | |
CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A47 | 0.72 | |
CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A48 | 0.72 | |
CR7 | [(4Z)-2-[(1S)-1,5-DIAMINOPENTYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A | 2A46 | 0.72 | |
NYG | [(4Z)-2-[(1S)-1,3-DIAMINO-3-OXOPROPYL]- 4-(4-HYDROXYBENZYLIDENE)-5-OXO- 4,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETIC ACID | A,B | 2OJK | 0.72 | |
CJO | [(2R,4R)-2-[(1R,2R)-1-amino-2-hydroxypropyl]- 4-(4-hydroxybenzyl)-5-oxoimidazolidin- 1-yl]acetic acid | A | 2QT2 | 0.73 | |
CTA | CYCLOTHEONAMIDE A | A | 1TYN | 0.76 | |
CMQ | N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)- 2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]- L-LEUCINAMIDE | A,B,C,D,E,F, G,H,I,J,K,L, M,N | 2FZS | 0.7 | |
ZYA | BENZOYL-TYROSINE-ALANINE-METHYL KETONE | A | 1AIM | 0.72 | |
UR2 | 4-[3-CARBOXYMETHYL-3-(4-PHOSPHONOOXY- BENZYL)-UREIDO]-4-[(3-CYCLOHEXYL- PROPYL)-METHYL-CARBAMOYL]BUTYRIC ACID | A | 1SKJ | 0.7 | |
BBB | 1-((2-HYDROXYETHOXY)METHYL)-5-(3- (BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE- 2,4(1H,3H)-DIONE | A,B,C,D,E,F | 1U1G | 0.71 | |
3XH | 3-Hydroxyhippuric acid | A | 3E9K | 0.7 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.8 | |
YBY | N-{[(1S)-1-carboxy-2-(4-hydroxy- 3-iodophenyl)ethyl]carbamoyl}-L- glutamic acid | A | 3D7F | 0.71 | |
TI2 | (2-SULFANYL-3-PHENYLPROPANOYL)- PHE-TYR | A | 1QF0 | 0.72 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGO | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E | 3CGL | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1G7K | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1GGX | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2ARL | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9I | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 2VAD | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 2H8Q | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D | 1ZGP | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2IB5 | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOV | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A | 1MOU | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2VAE | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2P4M | 0.71 | |
CRQ | [2-(3-CARBAMOYL-1-IMINO-PROPYL)- 4-(4-HYDROXY-BENZYLIDENE)-5-OXO- 4,5-DIHYDRO-IMIDAZOL-1-YL]-ACETIC ACID | A,B,C,D,E,F, G,H | 2C9J | 0.71 | |
MOY | [(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL- 2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN- 5-YL](PHENYL)METHANONE | A,B | 2IEH | 0.72 | |
HBZ | N-{[(4-hydroxyphenyl)carbonyl]carbamoyl}- beta-D-glucopyranosylamine | A | 2QN7 | 0.7 | |
TYP | CYCLO-(L-TYROSINE-L-PROLINE) INHIBITOR | A,B | 1W1Y | 0.74 | |
TYC | L-TYROSINAMIDE | A | 2BF9 | 0.71 | |
TYC | L-TYROSINAMIDE | A | 2OCI | 0.71 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.79 | |
CCY | 2-(1-AMINO-2-MERCAPTO-ETHYL)-5- (4-HYDROXY-BENZYL)-3-(ETHANOYL)- 3,5-DIHYDRO-IMIDAZOL-4-ONE | A | 1EMK | 0.73 | |
GAH | N-{[(2S)-1-(N-{[4-({[AMINO(IMINO)METHYL]AMINO}METHYL)CYCLOHEXYL]CARBONYL}- 3-CYCLOHEXYL-L-ALANYL)AZETIDIN- 2-YL]CARBONYL}-L-TYROSYL-N~6~-[AMINO(IMINO)METHYL]- L-LYSINAMIDE | A,H | 1XM1 | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AH8 | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1HCJ | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7S | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7T | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 2AHA | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EME | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B | 1KP5 | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EMM | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 1EML | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1W7U | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A,B,C,D | 1EMC | 0.74 | |
CSY | [4-(4-HYDROXY-BENZYL)-2-(2-HYDROXY- 1-METHYL-ETHYL)-5-OXO-IMIDAZOLIDIN- 1-YL]-ACETIC ACID | A | 2HPW | 0.74 | |
CZO | [(2R,4S)-2-[(1S,2R)-1-amino-2-hydroxypropyl]- 2-hydroxy-4-(4-hydroxybenzyl)-5- oxoimidazolidin-1-yl]acetic acid | A | 2QRF | 0.72 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1JLA | 0.7 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1RT2 | 0.7 | |
TNK | 6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL | A | 1S1V | 0.7 | |
HQQ | 5-METHYL-5-(4-PHENOXY-PHENYL)-PYRIMIDINE- 2,4,6-TRIONE | A,B,C | 1G4K | 0.71 | |
CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B | 1XAE | 0.71 | |
CH7 | [(4Z)-4-(4-HYDROXYBENZYLIDENE)- 5-OXO-2-(3,4,5,6-TETRAHYDROPYRIDIN- 2-YL)-4,5-DIHYDRO-1H-IMIDAZOL-1- YL]ACETIC ACID | A,B,C,D | 2OGR | 0.71 | |
NLT | N-DODECANOYL-L-TYROSINE | A,B,C,D,E,F, G,H | 2G0B | 0.73 | |
3QC | (4R)-4-(3-HYDROXYPHENYL)-N,N,7,8- TETRAMETHYL-3,4-DIHYDROISOQUINOLINE- 2(1H)-CARBOXAMIDE | A,B | 2FME | 0.73 |